Genomic Vision propose des solutions fondées sur
l’analyse structurale de l’ADN et des tests génétiques
dans les domaines du cancer, des maladies héréditaires
rares et de la pharmaco-génomique.



Frédéric Tarbouriech

MBA, Vice-President Finance & Corporate Development


With over 20 years of professional experience in various financial positions as financial advisor, then within the European leader of clinical diagnostic, Frédéric Tarbouriech joined Genomic Vision in 2017 to manage and finance the development of the business.

Prior to joining Genomic Vision, Frederic spent 6 years at Labco/Synlab – a leading European clinical diagnostics company – where he was Group Consolidation, Internal Control and Accounting director. In this capacity, he established a robust reporting process, supported Labco’s strong growth, and was closely involved in a number of strategic projects, notably the Labco IPO project, and high yield bond issuances. 

Frédéric started his career as a financial auditor and transaction services advisor. He was at Arthur Andersen and Ernst & Young for 11 years. He earned an MBA from Essec Business School.